Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wallis

Showing results (301-310 of 506) with videos related to

Pageof 51
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 23, 2024
Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE StudySoumyajit Roy, Fred Saad, Christopher J D Wallis, et al.
Urologic Oncology|March 2, 2026
Real-world functional and oncologic outcomes of prostate gland ablation vs. standard of care therapies for localized prostate: A retrospective cohort study using the TriNetX databaseEusebio Luna Velasquez, Renil S Titus, Vatsala Mundra, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 26, 2018
The association between physician trust and prostate-specific antigen screening: Implications for shared decision-makingZachary Klaassen, Christopher J D Wallis, Hanan Goldberg, et al.
Urology|September 6, 2020
The Impact of Hospital Volume on Short-term and Long-term Outcomes for Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaWilson Sui, Christopher J D Wallis, Amy N Luckenbaugh, et al.
The American Surgeon|November 30, 2017
Peripheral Nerve Injury during Abdominal-Pelvic Surgery: Analysis of the National Surgical Quality Improvement Program DatabaseChristopher J D Wallis, Sarah Peltz, James Byrne, et al.
Oncotargets and Therapy|May 21, 2020
Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic LandscapeMary E Hall, Heather L Huelster, Amy N Luckenbaugh, et al.
Cancer|December 19, 2018
The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entityThenappan Chandrasekar, Hanan Goldberg, Zachary Klaassen, et al.
Cancer Causes & Control : CCC|May 8, 2021
Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approachMary E Hall, Bimal Bhindi, Amy N Luckenbaugh, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Real-World Treatment Patterns and Outcomes of Intraluminal Ablative Therapies in Noninvasive Urethral Carcinoma: A National Cancer Database AnalysisEusebio Luna Velasquez, Vatsala Mundra, Renil S Titus, et al.
Urology|June 14, 2016
Morbidity and Mortality of Radical Nephrectomy for Patients With Disseminated Cancer: An Analysis of the National Surgical Quality Improvement Program DatabaseChristopher J D Wallis, Georg Bjarnason, James Byrne, et al.
Pageof 51

Showing results (301-310 of 506) with videos related to

Sort By:
Pageof 51
European Journal of Cancer (Oxford, England : 1990)|January 23, 2024
Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE StudySoumyajit Roy, Fred Saad, Christopher J D Wallis, et al.
Urologic Oncology|March 2, 2026
Real-world functional and oncologic outcomes of prostate gland ablation vs. standard of care therapies for localized prostate: A retrospective cohort study using the TriNetX databaseEusebio Luna Velasquez, Renil S Titus, Vatsala Mundra, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 26, 2018
The association between physician trust and prostate-specific antigen screening: Implications for shared decision-makingZachary Klaassen, Christopher J D Wallis, Hanan Goldberg, et al.
Urology|September 6, 2020
The Impact of Hospital Volume on Short-term and Long-term Outcomes for Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaWilson Sui, Christopher J D Wallis, Amy N Luckenbaugh, et al.
The American Surgeon|November 30, 2017
Peripheral Nerve Injury during Abdominal-Pelvic Surgery: Analysis of the National Surgical Quality Improvement Program DatabaseChristopher J D Wallis, Sarah Peltz, James Byrne, et al.
Oncotargets and Therapy|May 21, 2020
Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic LandscapeMary E Hall, Heather L Huelster, Amy N Luckenbaugh, et al.
Cancer|December 19, 2018
The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entityThenappan Chandrasekar, Hanan Goldberg, Zachary Klaassen, et al.
Cancer Causes & Control : CCC|May 8, 2021
Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approachMary E Hall, Bimal Bhindi, Amy N Luckenbaugh, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Real-World Treatment Patterns and Outcomes of Intraluminal Ablative Therapies in Noninvasive Urethral Carcinoma: A National Cancer Database AnalysisEusebio Luna Velasquez, Vatsala Mundra, Renil S Titus, et al.
Urology|June 14, 2016
Morbidity and Mortality of Radical Nephrectomy for Patients With Disseminated Cancer: An Analysis of the National Surgical Quality Improvement Program DatabaseChristopher J D Wallis, Georg Bjarnason, James Byrne, et al.
Pageof 51